A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
- Published In:
- The New England journal of medicine, 389(1), 22-32 (2023)
- Authors:
- Wedemeyer, Heiner(2), Aleman, Soo, Brunetto, Maurizia Rossana, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Manuilov, Dmitry, Suri, Vithika, An, Qi, Da, Ben, Flaherty, John, Osinusi, Anu, Liu, Yang, Merle, Uta, Schulze Zur Wiesch, Julian, Zeuzem, Stefan, Ciesek, Sandra, Cornberg, Markus, Lampertico, Pietro
- Database ID:
- RPEP-07537
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07537APA
Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia Rossana; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; Berger, Annemarie; Manuilov, Dmitry; Suri, Vithika; An, Qi; Da, Ben; Flaherty, John; Osinusi, Anu; Liu, Yang; Merle, Uta; Schulze Zur Wiesch, Julian; Zeuzem, Stefan; Ciesek, Sandra; Cornberg, Markus; Lampertico, Pietro. (2023). A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.. The New England journal of medicine, 389(1), 22-32. https://doi.org/10.1056/NEJMoa2213429
MLA
Wedemeyer, Heiner, et al. "A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.." The New England journal of medicine, 2023. https://doi.org/10.1056/NEJMoa2213429
RethinkPeptides
RethinkPeptides Research Database. "A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepati..." RPEP-07537. Retrieved from https://rethinkpeptides.com/research/wedemeyer-2023-a-phase-3-randomized
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.